Int J Cardiol. 2014 Jan 22. pii: S0167-5273(14)00195-8. doi: 10.1016/j.ijcard.2013.12.313. [Epub ahead of print]
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry.
Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G.
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry.
Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G.
Am J Respir Crit Care Med. 2014 Feb 1;189(3):345-55. doi: 10.1164/rccm.201311-1954ST.
An official american thoracic society statement: pulmonary hypertension phenotypes.
Dweik RA, Rounds S, Erzurum SC, Archer S, Fagan K, Hassoun PM, Hill NS, Humbert M, Kawut SM, Krowka M, Michelakis E, Morrell NW, Stenmark K, Tuder RM, Newman J; ATS Committee on Pulmonary Hypertension Phenotypes.
An official american thoracic society statement: pulmonary hypertension phenotypes.
Dweik RA, Rounds S, Erzurum SC, Archer S, Fagan K, Hassoun PM, Hill NS, Humbert M, Kawut SM, Krowka M, Michelakis E, Morrell NW, Stenmark K, Tuder RM, Newman J; ATS Committee on Pulmonary Hypertension Phenotypes.
Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3.
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G
Allergy. 2014 Mar 10. doi: 10.1111/all.12379. [Epub ahead of print]
Enhanced glucocorticoid-induced leucine zipper in dendritic cells induces allergen-specific regulatory CD4+ T-cells in respiratory allergies.
Karaki S1, Garcia G, Tcherakian C, Capel F, Tran T, Pallardy M, Humbert M, Emilie D, Godot V.
Enhanced glucocorticoid-induced leucine zipper in dendritic cells induces allergen-specific regulatory CD4+ T-cells in respiratory allergies.
Karaki S1, Garcia G, Tcherakian C, Capel F, Tran T, Pallardy M, Humbert M, Emilie D, Godot V.
Eur Respir J. 2014 Mar 13. [Epub ahead of print]
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Sitbon O, Jays X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G.
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Sitbon O, Jays X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G.
Histopathology. 2014 Apr 4. doi: 10.1111/his.12429. [Epub ahead of print]
Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.
Ghigna MR1, Hamdi S, Petitpretz P, Rohnean A, Florea V, Mussot S, Dartevelle P, Dorfmuller P, Tu L, Thuillet R, Guignabert C, Thomas-de-Montpreville V.
Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.
Ghigna MR1, Hamdi S, Petitpretz P, Rohnean A, Florea V, Mussot S, Dartevelle P, Dorfmuller P, Tu L, Thuillet R, Guignabert C, Thomas-de-Montpreville V.
Ther Adv Respir Dis. 2014 Apr 11. [Epub ahead of print]
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension.
Steriade A1, Seferian A, Jaïs X, Savale L, Jutant EM, Parent F, Sitbon O, Humbert M, Simmoneau G, Montani D.
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension.
Steriade A1, Seferian A, Jaïs X, Savale L, Jutant EM, Parent F, Sitbon O, Humbert M, Simmoneau G, Montani D.
Expert Rev Respir Med. 2014 Apr 18. [Epub ahead of print]
KCNK3: new gene target for pulmonary hypertension?
Girerd B1, Perros F, Antigny F, Humbert M, Montani D.
KCNK3: new gene target for pulmonary hypertension?
Girerd B1, Perros F, Antigny F, Humbert M, Montani D.